GV

GV

USD

Visionary Holdings Inc. Common Shares

$1.470+0.030 (2.083%)

السعر في الوقت الحقيقي

Consumer Defensive
Education & Training Services
كندا

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$1.440

الأعلى

$1.490

الأدنى

$1.420

الحجم

0.03M

أساسيات الشركة

القيمة السوقية

6.0M

الصناعة

Education & Training Services

البلد

Canada

إحصاءات التداول

متوسط الحجم

1.91M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $1.022الحالي $1.470الأعلى $9.6

أخبار ذات صلة

PR Newswire

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its ...

عرض المزيد
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
PR Newswire

Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully...

عرض المزيد
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
PR Newswire

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation,...

عرض المزيد
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
PR Newswire

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the...

عرض المزيد
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.